Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial

NCT02615860 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT02615860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial
Lead sponsor
University Hospital, Essen
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
December 31, 2021
Enrollment
560 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal intraepithelial neoplasia (ain) in hiv-infected patients